News
EDA Chairman Meets with Representatives of the Chamber of Pharmaceutical Industry to Discuss Enhancing Investment and Supporting the Pharmaceutical Industry
Dr. Ali Al-Ghamrawy, Chairman of the EDA, held a meeting with representatives of the Chamber of Pharmaceutical Industry, headed by Dr. Gamal El-Leithy, Chairman of the Chamber, to discuss several issues of mutual interest and explore proposals for developing the regulatory environment and supporting the sustainability of Egypt’s pharmaceutical industry.
The meeting reflects the EDA’s approach to strengthening ongoing communication and coordination with industry partners.
The meeting addressed ways to enhance cooperation between the EDA and industry representatives, as well as challenges facing the pharmaceutical sector and proposed solutions. Discussions focused on improving the regulatory working environment, facilitating procedures in accordance with applicable rules and regulations, supporting the competitiveness of the national pharmaceutical industry, and maintaining stability in the Egyptian pharmaceutical market.
The EDA reaffirmed its commitment to balancing regulatory oversight requirements with support for the sustainability of the national pharmaceutical industry, ensuring the continued availability of pharmaceutical products and meeting the needs of the Egyptian market, while keeping the highest standards of quality, safety, and efficacy.
For their part, representatives of the Chamber of Pharmaceutical Industry commended the EDA’s efforts to strengthen dialogue and direct communication with industry partners and to listen to the challenges and proposals raised. They emphasized the importance of continuing this collaborative approach to support the development of the pharmaceutical sector, facilitate procedures, and enhance stability in the pharmaceutical market.
Both sides underscored the importance of continued consultation and coordination, as well as the careful consideration of the proposals raised in accordance with the applicable regulatory frameworks, in a manner that serves the public interest and supports the growth and competitiveness of the national pharmaceutical industry.
This meeting reflects the EDA’s partnership-based approach and ongoing engagement with all stakeholders across the pharmaceutical system, contributing to the development of the national pharmaceutical industry, enhancing pharmaceutical market stability, and ensuring the availability of safe, effective, and high-quality pharmaceutical products for Egyptian citizens.
Tags
EDA Chairman
Chamber of Pharmaceutical Industry